Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aloysius T Nchinda

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
ACS Medicinal Chemistry Letters|February 18, 2026
Optimizing Drug Discovery in Resource-Limited Settings: Multi-Parameter Optimization and Data-Driven WorkflowsAloysius T Nchinda, Karsten Menzel
Annals of the New York Academy of Sciences|January 3, 2006
Development of domain-selective angiotensin I-converting enzyme inhibitorsPierre Redelinghuys, Aloysius T Nchinda, Edward D Sturrock
Journal of Natural Products|August 23, 2003
Chromone studies. Part 13. Synthesis and electron-impact mass spectrometric studies of 5-hydroxy-2-isopropyl-7-methoxychromone, a constituent of the medicinal plant Baeckea frutescens, and side-chain analoguesChristopher A Gray, Perry T Kaye, Aloysius T Nchinda
Biological Chemistry|April 12, 2006
Novel ketomethylene inhibitors of angiotensin I-converting enzyme (ACE): inhibition and molecular modellingPierre Redelinghuys, Aloysius T Nchinda, Kelly Chibale, et al.
Bioorganic & Medicinal Chemistry Letters|June 21, 2006
Synthesis and molecular modeling of a lisinopril-tryptophan analogue inhibitor of angiotensin I-converting enzymeAloysius T Nchinda, Kelly Chibale, Pierre Redelinghuys, et al.
Bioorganic & Medicinal Chemistry Letters|June 21, 2006
Synthesis of novel keto-ACE analogues as domain-selective angiotensin I-converting enzyme inhibitorsAloysius T Nchinda, Kelly Chibale, Pierre Redelinghuys, et al.
Journal of Virology|February 29, 2008
Residue L143 of the foot-and-mouth disease virus leader proteinase is a determinant of cleavage specificityChristina Mayer, David Neubauer, Aloysius T Nchinda, et al.
Journal of Molecular Biology|February 16, 2006
Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor designHazel R Corradi, Sylva L U Schwager, Aloysius T Nchinda, et al.
Biochemistry|December 15, 2004
Positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides for defining substrate specificity of the angiotensin I-converting enzyme and development of selective C-domain substratesPatrícia A Bersanetti, Maria Claudina C Andrade, Dulce E Casarini, et al.
Biological Chemistry|June 30, 2009
Catalytic properties of recombinant dipeptidyl carboxypeptidase from Escherichia coli: a comparative study with angiotensin I-converting enzymeCarlos Eduardo L Cunha, Helena de Fátima Magliarelli, Thaysa Paschoalin, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
ACS Medicinal Chemistry Letters|February 18, 2026
Optimizing Drug Discovery in Resource-Limited Settings: Multi-Parameter Optimization and Data-Driven WorkflowsAloysius T Nchinda, Karsten Menzel
Annals of the New York Academy of Sciences|January 3, 2006
Development of domain-selective angiotensin I-converting enzyme inhibitorsPierre Redelinghuys, Aloysius T Nchinda, Edward D Sturrock
Journal of Natural Products|August 23, 2003
Chromone studies. Part 13. Synthesis and electron-impact mass spectrometric studies of 5-hydroxy-2-isopropyl-7-methoxychromone, a constituent of the medicinal plant Baeckea frutescens, and side-chain analoguesChristopher A Gray, Perry T Kaye, Aloysius T Nchinda
Biological Chemistry|April 12, 2006
Novel ketomethylene inhibitors of angiotensin I-converting enzyme (ACE): inhibition and molecular modellingPierre Redelinghuys, Aloysius T Nchinda, Kelly Chibale, et al.
Bioorganic & Medicinal Chemistry Letters|June 21, 2006
Synthesis and molecular modeling of a lisinopril-tryptophan analogue inhibitor of angiotensin I-converting enzymeAloysius T Nchinda, Kelly Chibale, Pierre Redelinghuys, et al.
Bioorganic & Medicinal Chemistry Letters|June 21, 2006
Synthesis of novel keto-ACE analogues as domain-selective angiotensin I-converting enzyme inhibitorsAloysius T Nchinda, Kelly Chibale, Pierre Redelinghuys, et al.
Journal of Virology|February 29, 2008
Residue L143 of the foot-and-mouth disease virus leader proteinase is a determinant of cleavage specificityChristina Mayer, David Neubauer, Aloysius T Nchinda, et al.
Journal of Molecular Biology|February 16, 2006
Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor designHazel R Corradi, Sylva L U Schwager, Aloysius T Nchinda, et al.
Biochemistry|December 15, 2004
Positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides for defining substrate specificity of the angiotensin I-converting enzyme and development of selective C-domain substratesPatrícia A Bersanetti, Maria Claudina C Andrade, Dulce E Casarini, et al.
Biological Chemistry|June 30, 2009
Catalytic properties of recombinant dipeptidyl carboxypeptidase from Escherichia coli: a comparative study with angiotensin I-converting enzymeCarlos Eduardo L Cunha, Helena de Fátima Magliarelli, Thaysa Paschoalin, et al.
Pageof 3